RT Journal Article SR Electronic T1 Donor acquired visceral leishmaniasis following liver transplantation JF Frontline Gastroenterology JO Frontline Gastroenterol FD BMJ Publishing Group Ltd SP 690 OP 694 DO 10.1136/flgastro-2020-101659 VO 12 IS 7 A1 Amritpal Dhaliwal A1 Abhishek Chauhan A1 Dinesh Aggarwal A1 Pretin Davda A1 Miruna David A1 Rasoul Amel-Kashipaz A1 Rachel Brown A1 Martin Dedicoat A1 Fiona Clark A1 Tahir Shah A1 Ahmed Mohamed Elsharkawy A1 Ines Ushiro-Lumb A1 Peter Chiodini A1 Omar El-Sherif A1 Matthew Armstrong A1 James W Ferguson YR 2021 UL http://fg.bmj.com/content/12/7/690.abstract AB Patients who undergo solid organ transplantation are at risk of opportunistic infection associated with immunosuppression. We report a case of confirmed donor derived visceral leishmaniasis (VL), in a patient following liver transplantation causing fever and pancytopenia. The diagnosis was confirmed by bone marrow biopsy, with confirmed positive donor serology, with no other route of transmission. To our knowledge, this is the first case report in the United Kingdom and Europe, of confirmed organ donor transmission of VL. This case report highlights an important consideration of donor derived infections, in the context of solid organ transplantation.